Form 4: Texas Instruments Executive Exercises Options and Sells Shares
SEC Form 4 Filing
Texas Instruments' Senior Vice President, Gary Mark, exercised stock options and sold shares on August 29, 2024, according to a Form 4 filing with the SEC.
Summary
- On August 29, 2024, Gary Mark, a Senior Vice President at Texas Instruments, exercised options to acquire 15,165 shares of common stock at a price of $79.26 per share.
- Simultaneously, Mr. Mark sold a total of 15,165 shares of Texas Instruments common stock in multiple transactions.
- The sales were executed at weighted average prices of $211.797, $212.7012, and $213.5023.
- Following these transactions, Mr. Mark directly owns 45,143 shares of Texas Instruments common stock.
- Mr. Mark also holds options to purchase 0 shares of Texas Instruments common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing insider transactions, which is neutral in sentiment.
Industry Context
This filing reflects routine insider transactions and provides insight into executive compensation and stock ownership at Texas Instruments. It's common for executives to exercise stock options and sell shares for personal financial management.
Comparison to Industry Standards
- Executive compensation practices, including stock options, are standard across the semiconductor industry.
- Companies like Intel, NVIDIA, and Qualcomm also utilize stock options as part of their executive compensation packages.
- The timing and volume of insider sales can vary based on individual financial planning and company performance.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 01/26/2018 | Date option became exercisable in four equal annual installments |
| 01/26/2027 | Expiration date of NQ Stock Option |
| 08/29/2024 | Date of transaction: exercise of stock options and sale of shares |
| 09/03/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.